Elevation Oncology Inc (ELEV) — Financial Flexibility Index
Elevation Oncology Inc (ELEV) has a Financial Flexibility Index of -0.36x as of March 2025. Free cash flow of $-12.71 Million (operating CF $-12.71 Million minus capex $0.00) represents 0% of total liabilities ($35.49 Million). Check ELEV goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Elevation Oncology Inc Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Elevation Oncology Inc across 6 annual periods. For the full cash flow conversion analysis, see ELEV cash flow metrics.
Annual Financial Flexibility Index for Elevation Oncology Inc (2019–2024)
Year-by-year free cash flow to debt coverage for Elevation Oncology Inc. Explore ELEV debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.02x | $-36.36 Million | $-36.36 Million | $35.60 Million | ▲ +37.7% |
| 2023 | -1.64x | $-56.18 Million | $-56.18 Million | $34.28 Million | ▲ +13.4% |
| 2022 | -1.89x | $-85.40 Million | $-85.48 Million | $45.13 Million | ▲ +44.7% |
| 2021 | -3.42x | $-30.08 Million | $-30.17 Million | $8.80 Million | ▼ -2808.2% |
| 2020 | -0.12x | $-12.23 Million | $-12.30 Million | $103.99 Million | ▲ +83.0% |
| 2019 | -0.69x | $-5.38 Million | $-5.45 Million | $7.79 Million | — |